4//SEC Filing
Gilmore Geoffrey 4
Accession 0001104659-18-004317
CIK 0001261249other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:16 PM ET
Size
13.1 KB
Accession
0001104659-18-004317
Insider Transaction Report
Form 4
Gilmore Geoffrey
General Counsel
Transactions
- Tax Payment
Common Stock
2018-01-25$3.32/sh−5,768$19,150→ 11,732 total - Award
Employee Stock Options (Right to Buy)
2018-01-24+107,000→ 107,000 totalExercise: $3.46Exp: 2028-01-23→ Common Stock (107,000 underlying) - Exercise/Conversion
Common Stock
2018-01-25+17,500→ 17,500 total - Exercise/Conversion
Restricted Stock Units
2018-01-25−17,500→ 33,980 total→ Common Stock (17,500 underlying) - Award
Restricted Stock Units
2018-01-24+16,480→ 51,480 total→ Common Stock (16,480 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]This option was granted on January 24, 2018. 25% of the shares subject to the stock option vest on January 24, 2019, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 24, 2022.
- [F3]The restricted stock units were granted on January 24, 2018 and will be fully vested and delivered on January 24, 2019.
- [F4]On January 25, 2017, the reporting person was granted 35,000 restricted stock units that vest as follows: 17,500 units vested and were delivered on January 25, 2018, and 17,500 units will vest and be delivered on January 25, 2019.
Documents
Issuer
AGILE THERAPEUTICS INC
CIK 0001261249
Entity typeother
Related Parties
1- filerCIK 0001429407
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 5:16 PM ET
- Size
- 13.1 KB